Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32)
The summary for the Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32): This Funding Opportunity Announcement (FOA) encourages Revision applications from currently active NIA and NINR institutional training grants that propose a new research emphasis on Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) or propose to expand the scope of AD/ADRD research on their existing training grant. The revision should provide for the seamless integration of AD/ADRD into the overall scientific emphasis of the ongoing training program.
Federal Grant Title: | Revision Awards to Institutional Training Programs to Advance Research on Alzheimers Disease and Alzheimer's Disease Related Dementias (T32) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-17-072 |
Type of Funding: | Grant |
CFDA Numbers: | 93.361, 93.866 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | January 25th, 2019 |
Original Application Deadline: | January 25th, 2019 |
Posted Date: | December 9th, 2016 |
Creation Date: | December 9th, 2016 |
Archive Date: | February 25th, 2019 |
Total Program Funding: | |
Maximum Federal Grant Award: | $300,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | December 9th, 2016 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. See Funding Opportunity for Eligibility Details
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-17-072.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants ...
- • Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R...
- • Short Courses in Social Determinants of Health for Research Education in Nursing Research ...
- • PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...
- • Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Healt...
- • Ninr Career Transition Award (K22)
- • Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fell...
- • NINR Mentored Research Scientist Development Award for Underrepresented or Disadvantaged I...
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)